Latest Manufacturing And Revenue News

Synertec Corporation Limited reported a 20% increase in revenue to $10.2 million for the half-year ended 31 December 2025, alongside a 40% improvement in net loss after tax. The company’s Powerhouse renewable energy system continues to gain traction, supported by strategic partnerships and expanded manufacturing.

Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.

TZ Limited reported a quarterly cash outflow of A$790,000 impacted by payment timing but maintains full-year revenue guidance amid strategic advances in smart locker and data centre security sectors.

Magontec Limited posted a 29% decline in revenue to $29.47 million for the first half of 2025, alongside a net loss of $3.96 million, while shutting down its Qinghai subsidiary. The results highlight ongoing challenges in the steel manufacturing sector.

Sprintex Limited reported a 26% revenue increase for FY25 but also a 37% rise in net loss, as it accelerates global expansion through key distribution deals and manufacturing upgrades.

Korvest Ltd reported a strong FY25 with revenues up 16.2% and net profit after tax rising 19.1%, supported by major infrastructure projects and operational resilience. The company declared a fully franked final dividend plus a special dividend, while advancing plans to expand its Kilburn manufacturing site.

Elsight Limited reports record-breaking revenue growth in Q2 and H1 2025, driven by major defence contracts and expanding market opportunities, positioning the company for profitability later this year.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

IDT Australia reports a robust 30% jump in quarterly revenue to $4.1 million, driven by strong contract wins and a $62 million pipeline of open proposals, signaling sustained growth in pharmaceutical manufacturing.

Audinate Group Limited's half-year results reveal a sharp 38.4% revenue decline and a $2.2 million net loss, driven by reduced chip demand as customers clear inventory. Yet, growth in OEM partnerships hints at potential recovery.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.